Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premature Birth | 2 | 2022 | 76 | 0.390 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 266 | 0.380 |
Why?
|
| Spike Glycoprotein, Coronavirus | 3 | 2022 | 84 | 0.290 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 220 | 0.220 |
Why?
|
| Pandemics | 2 | 2023 | 280 | 0.210 |
Why?
|
| Chorioamnionitis | 1 | 2022 | 10 | 0.210 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2022 | 4 | 0.200 |
Why?
|
| Dried Blood Spot Testing | 1 | 2021 | 22 | 0.200 |
Why?
|
| Somatotypes | 1 | 2021 | 3 | 0.190 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2023 | 137 | 0.190 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 176 | 0.180 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 251 | 0.180 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 137 | 0.170 |
Why?
|
| Pneumococcal Infections | 1 | 2023 | 287 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2023 | 360 | 0.160 |
Why?
|
| Infant, Newborn | 4 | 2022 | 1410 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 507 | 0.150 |
Why?
|
| Hypertension | 1 | 2022 | 397 | 0.150 |
Why?
|
| Pregnancy | 4 | 2023 | 1815 | 0.140 |
Why?
|
| Humans | 9 | 2023 | 14077 | 0.140 |
Why?
|
| Female | 6 | 2023 | 8751 | 0.120 |
Why?
|
| HIV Infections | 2 | 2022 | 4946 | 0.120 |
Why?
|
| Male | 4 | 2023 | 6489 | 0.090 |
Why?
|
| South Africa | 4 | 2023 | 7312 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2023 | 1675 | 0.070 |
Why?
|
| Aged | 2 | 2022 | 1650 | 0.070 |
Why?
|
| Infant | 2 | 2023 | 2145 | 0.070 |
Why?
|
| Child | 2 | 2023 | 2180 | 0.070 |
Why?
|
| Hospitals | 1 | 2023 | 102 | 0.050 |
Why?
|
| Placenta | 1 | 2022 | 43 | 0.050 |
Why?
|
| Birth Weight | 1 | 2022 | 78 | 0.050 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2022 | 8 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 112 | 0.050 |
Why?
|
| Length of Stay | 1 | 2022 | 43 | 0.050 |
Why?
|
| Seizures | 1 | 2021 | 20 | 0.050 |
Why?
|
| Respiratory Tract Diseases | 1 | 2021 | 21 | 0.050 |
Why?
|
| Vero Cells | 1 | 2021 | 6 | 0.050 |
Why?
|
| Protein Domains | 1 | 2021 | 10 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2022 | 90 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 12 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2021 | 11 | 0.050 |
Why?
|
| Autopsy | 1 | 2022 | 131 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2021 | 22 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 46 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2021 | 17 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 409 | 0.050 |
Why?
|
| Adult | 2 | 2022 | 5664 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2021 | 10 | 0.050 |
Why?
|
| Athletes | 1 | 2021 | 20 | 0.050 |
Why?
|
| Comorbidity | 1 | 2022 | 184 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2021 | 106 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 101 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 137 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 285 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2022 | 467 | 0.040 |
Why?
|
| Animals | 1 | 2021 | 1063 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1377 | 0.040 |
Why?
|
| Adolescent | 1 | 2021 | 2858 | 0.030 |
Why?
|
| Middle Aged | 1 | 2022 | 3425 | 0.030 |
Why?
|